The recent shareholder update already stated they transferred manufacturing to another entity, but sure you can run with Flowerpot's narrative.

Aren't you even curious who the other entity is?

Quote:

---

We have also successfully transferred our manufacturing technology allowing us to manufacture leronlimab at scale in preparation for clinical trials and potential FDA approval.

---